BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9110460)

  • 1. [Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].
    Cattalini M; Lerario AC
    Rev Assoc Med Bras (1992); 1996; 42(2):109-14. PubMed ID: 9110460
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract]   [Full Text] [Related]  

  • 3. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibitors and diabetic complications.
    Tomlinson DR; Willars GB; Carrington AL
    Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF; Wyman M; Oates PJ
    Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of diabetic complications.
    Altan VM
    Curr Med Chem; 2003 Aug; 10(15):1317-27. PubMed ID: 12871132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldose reductase inhibitors: recent developments.
    Sarges R; Oates PJ
    Prog Drug Res; 1993; 40():99-161. PubMed ID: 8356214
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
    Suzen S; Buyukbingol E
    Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase: a window to the treatment of diabetic complications?
    Crabbe MJ; Goode D
    Prog Retin Eye Res; 1998 Jul; 17(3):313-83. PubMed ID: 9695797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 14. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Kador PF; Kinoshita JH; Sharpless NE
    J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
    [No Abstract]   [Full Text] [Related]  

  • 15. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
    Tomlinson DR; Stevens EJ; Diemel LT
    Trends Pharmacol Sci; 1994 Aug; 15(8):293-7. PubMed ID: 7940997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical composition for treating diabetic cataracts: a patent evaluation (WO2015026380A1).
    Hao X; Han Z; Zhu C
    Expert Opin Ther Pat; 2016 Jun; 26(6):731-5. PubMed ID: 26967920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications.
    Varma SD
    Prog Clin Biol Res; 1986; 213():343-58. PubMed ID: 3086893
    [No Abstract]   [Full Text] [Related]  

  • 19. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on molecules: aldose reductase.
    Anil Kumar P; Bhanuprakash Reddy G
    Exp Eye Res; 2007 Dec; 85(6):739-40. PubMed ID: 16997295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.